Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RenewDisc Trial: A Prospective Observational Study Comparing Endoscopic Discectomy and Autologous Mesenchymal Stem Cell Therapy in Patients With Discogenic Low Back Pain

NCT07338877 is registered in ClinicalTrials.gov with EPC Education s.r.o. as lead sponsor.

NCT NCT07338877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07338877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RenewDisc Trial: A Prospective Observational Study Comparing Endoscopic Discectomy and Autologous Mesenchymal Stem Cell Therapy in Patients With Discogenic Low Back Pain
Lead sponsor
EPC Education s.r.o.
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 1, 2024
Completion date
December 31, 2027
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low back pain, discogenic low back pain, intervertebral disc degeneration, lumbar disc disease